191 related articles for article (PubMed ID: 22216870)
1. Physician prescribing behavior and its impact on patient-level outcomes.
Joyce GF; Carrera MP; Goldman DP; Sood N
Am J Manag Care; 2011 Dec; 17(12):e462-71. PubMed ID: 22216870
[TBL] [Abstract][Full Text] [Related]
2. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA.
Mintzes B; Barer ML; Kravitz RL; Bassett K; Lexchin J; Kazanjian A; Evans RG; Pan R; Marion SA
CMAJ; 2003 Sep; 169(5):405-12. PubMed ID: 12952801
[TBL] [Abstract][Full Text] [Related]
3. Personal Formularies of Primary Care Physicians Across 4 Health Care Systems.
Galanter W; Eguale T; Gellad W; Lambert B; Mirica M; Cashy J; Salazar A; Volk LA; Falck S; Shilka J; Van Dril E; Jarrett J; Zulueta J; Fiskio J; Orav J; Norwich D; Bennett S; Seger D; Wright A; Linder JA; Schiff G
JAMA Netw Open; 2021 Jul; 4(7):e2117038. PubMed ID: 34264328
[TBL] [Abstract][Full Text] [Related]
4. Physicians' opinions about responsibility for patient out-of-pocket costs and formulary prescribing in two Midwestern states.
Khan S; Sylvester R; Scott D; Pitts B
J Manag Care Pharm; 2008 Oct; 14(8):780-9. PubMed ID: 18983207
[TBL] [Abstract][Full Text] [Related]
5. Do doctors in dispensing practices with a financial conflict of interest prescribe more expensive drugs? A cross-sectional analysis of English primary care prescribing data.
Goldacre B; Reynolds C; Powell-Smith A; Walker AJ; Yates TA; Croker R; Smeeth L
BMJ Open; 2019 Feb; 9(2):e026886. PubMed ID: 30813120
[TBL] [Abstract][Full Text] [Related]
6. Effects of Physician-directed Pharmaceutical Promotion on Prescription Behaviors: Longitudinal Evidence.
Datta A; Dave D
Health Econ; 2017 Apr; 26(4):450-468. PubMed ID: 26893065
[TBL] [Abstract][Full Text] [Related]
7. Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data.
Sharma M; Vadhariya A; Johnson ML; Marcum ZA; Holmes HM
BMC Health Serv Res; 2018 Apr; 18(1):236. PubMed ID: 29609611
[TBL] [Abstract][Full Text] [Related]
8. Pharmaceutical marketing strategies' influence on physicians' prescribing pattern in Lebanon: ethics, gifts, and samples.
Khazzaka M
BMC Health Serv Res; 2019 Jan; 19(1):80. PubMed ID: 30700295
[TBL] [Abstract][Full Text] [Related]
9. Childhood Attention-Deficit/Hyperactivity Disorder Prescribing by Prescriber Type and Specialty in Oregon Medicaid.
Klein TA; Panther S; Woo T; Odom-Maryon T; Daratha K
J Child Adolesc Psychopharmacol; 2016 Aug; 26(6):548-54. PubMed ID: 27135134
[TBL] [Abstract][Full Text] [Related]
10. What differentiates primary care physicians who predominantly prescribe diuretics for treating mild to moderate hypertension from those who do not? A comparative qualitative study.
Rochefort CM; Morlec J; Tamblyn RM
BMC Fam Pract; 2012 Feb; 13():9. PubMed ID: 22375684
[TBL] [Abstract][Full Text] [Related]
11. Effects of electronic prescribing on formulary compliance and generic drug utilization in the ambulatory care setting: a retrospective analysis of administrative claims data.
Ross SM; Papshev D; Murphy EL; Sternberg DJ; Taylor J; Barg R
J Manag Care Pharm; 2005 Jun; 11(5):410-5. PubMed ID: 15934800
[TBL] [Abstract][Full Text] [Related]
12. Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review.
Fickweiler F; Fickweiler W; Urbach E
BMJ Open; 2017 Sep; 7(9):e016408. PubMed ID: 28963287
[TBL] [Abstract][Full Text] [Related]
13. The lack of a relationship between physician payments from drug manufacturers and Medicare claims for abiraterone and enzalutamide.
Bandari J; Ayyash OM; Turner RM; Jacobs BL; Davies BJ
Cancer; 2017 Nov; 123(22):4356-4362. PubMed ID: 28749536
[TBL] [Abstract][Full Text] [Related]
14. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
15. Pharmaceutical payments to physicians may increase prescribing for opioids.
Nguyen TD; Bradford WD; Simon KI
Addiction; 2019 Jun; 114(6):1051-1059. PubMed ID: 30667135
[TBL] [Abstract][Full Text] [Related]
16. Influence of pharmaceutical marketing on Medicare prescriptions in the District of Columbia.
Wood SF; Podrasky J; McMonagle MA; Raveendran J; Bysshe T; Hogenmiller A; Fugh-Berman A
PLoS One; 2017; 12(10):e0186060. PubMed ID: 29069085
[TBL] [Abstract][Full Text] [Related]
17. The Association between Industry Payments and Brand-Name Prescriptions in Otolaryngologists.
Morse E; Hanna J; Mehra S
Otolaryngol Head Neck Surg; 2019 Oct; 161(4):605-612. PubMed ID: 31547772
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries.
DeJong C; Aguilar T; Tseng CW; Lin GA; Boscardin WJ; Dudley RA
JAMA Intern Med; 2016 Aug; 176(8):1114-1122. PubMed ID: 27322350
[TBL] [Abstract][Full Text] [Related]
19. New chronic disease medication prescribing by nurse practitioners, physician assistants, and primary care physicians: a cohort study.
Marcum ZA; Bellon JE; Li J; Gellad WF; Donohue JM
BMC Health Serv Res; 2016 Jul; 16():312. PubMed ID: 27464570
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of prescribing trends and patterns of claims within the Preferred Drugs Initiative in Ireland (2011
McDowell R; Bennett K; Moriarty F; Clarke S; Barry M; Fahey T
BMJ Open; 2018 Apr; 8(4):e019315. PubMed ID: 29678966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
